logo

Frequency Therapeutics (FREQ)



Trade FREQ now with
  Date
  Headline
3/15/2022 7:35:39 AM Frequency Therapeutics Q4 Net Loss $21.5 Mln Vs. Loss $10.2 Mln Prior Year
12/9/2021 7:37:42 AM Frequency Therapeutics : FX-322 Associated With Hearing Signal
10/21/2021 7:35:54 AM Frequency Therapeutics Says First Subject Dosed In FX-322 Phase 2b Acquired Sensorineural Hearing Loss Study
9/22/2021 7:38:01 AM FREQ : Results Suggest Hearing Of Individuals Administered With Single Dose Of FX-322 May Improve Over Extended Periods
8/12/2021 7:37:55 AM Frequency Therapeutics Q2 Net Loss $17.7 Mln Vs. $6.0 Mln Prior Year
5/13/2021 7:34:27 AM Frequency Therapeutics Q1 Loss Per Share $0.60 Vs Loss $0.16 Last Year
4/13/2021 7:11:59 AM Frequency Therapeutics Expands Clinical Development Team With The Addition Of Jeffery Lichtenhan
2/8/2021 7:11:26 AM Frequency Therapeutics Appoints Kevin Franck As SVP, Strategic Marketing And New Product Planning